All PlansAdministrativeLow impact
Voluntary nationwide recall: Sucralfate (Nostrum – July)
UPMC Health Plan·Family Medicine, Internal Medicine, Gastroenterology +1 more·Pharmacy
We identified it
Jun 20, 2026
Summary
Nostrum Laboratories has issued a voluntary nationwide recall of all lots of Sucralfate Tablets USP 1 gram manufactured after June 2023 due to company bankruptcy and inability to confirm product quality standards. Healthcare providers should contact patients taking this medication and coordinate with pharmacies to identify affected lots.
Action Required
Immediately: Clinical staff should review patient medication lists to identify those taking Sucralfate Tablets USP 1 gram from Nostrum Labs (manufactured after June 2023). Contact affected patients to verify medication lot numbers with their pharmacy and coordinate with prescribing providers for potential medication switches. Document any patient communications in medical records.